New cancer drug enters human testing for Tough-to-Treat tumors
NCT ID NCT06373406
Summary
This early-stage clinical trial is testing a new drug called MHB036C in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The study will enroll about 200 participants to check for side effects and measure how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Chest Hospital
Shanghai, 200030, China
Conditions
Explore the condition pages connected to this study.